
Killick Capital
95 Water Street, 2nd Floor, St. John's, Newfoundland and Labrador, A1C 5W2, Canada
Overview
Killick Capital is a leading Atlantic Canadian private equity firm, dedicated to partnering with Atlantic Canadian businesses and Aerospace businesses. Our team of professionals work closely with portfolio companies to maximize success.
- Total investments
- 13
- Lead investments
- 4
- Investments · 12mo
- 2
- Active investors
- 1
Investment portfolio
- CoLab Software
Participated · Series C · Nov 2025
Founded in 2017, CoLab Software builds EngineeringOS, a cloud workspace that lets engineers run design reviews, annotate 2D/3D files, and apply AI agents to improve product quality. Its first agent, AutoReview, launched in June and already has more than 47,000 engineers on its waitlist, while early customers such as Ford, Lockheed Martin, GE Appliances, and Schneider Electric are using the core platform today. Management says these capabilities enable customers to shrink design cycles from months to hours and are driving seven-figure annual contracts. The company reports it is on track to nearly triple revenue in 2025, reflecting strong demand for AI in engineering workflows. CoLab plans to roll out additional AI agents, deepen integrations with other engineering software, and announce several strategic partnerships over the next 12 months. The platform also addresses a looming retirement-driven knowledge gap by capturing expert rationale that can be reused by future engineers.
- Sparrow BioAcoustics
Led · Equity · Oct 2025
Sparrow BioAcoustics is a Canadian medical-technology company that has developed Stethophone, the first FDA-cleared cardiac AI platform able to detect structural and rhythmic heart anomalies directly through a smartphone without external hardware. The system employs AI phonoscopy to identify murmurs, valvular disease, atrial fibrillation, and other conditions, delivering hospital-grade assessments with consumer-grade accessibility. In the past year, approximately 40,000 patients and practitioners used Stethophone, uncovering thousands of previously undetected cardiac anomalies. Clinical validation from the University of Washington Medical Center confirmed high accuracy in detecting valvular disease and atrial fibrillation, and additional evaluations are underway at several major U.S. and Canadian sites. The company is actively showcasing the product at leading cardiology conferences such as TCT and the American Heart Association Scientific Sessions. Fresh capital is earmarked to scale U.S. hospital deployments, sustain product momentum, and support growth initiatives. The recent $10 million raise marks a key milestone in financing Sparrow’s expansion and continued R&D efforts.
- QuickFacts
Participated · Equity · Aug 2024
QuickFacts offers a software platform that consolidates insurance carrier information into a searchable database, enabling side-by-side underwriting comparisons and streamlining brokerage workflows. The product is designed to reduce underwriting calls and can save users up to two hours per day. The company reports a user base of 100 brokerage clients and 2,500 users. QuickFacts was founded by Christy Barsalou and Jeff Barsalou in late 2020 and is based in Halifax, Canada. The startup recently closed an oversubscribed $2.0M funding round to support geographic expansion and team growth. The company has expanded into Canada’s Western provinces and plans to launch into Quebec and the U.S. with this funding. It also plans to add four new staff members this year to support growth.
- CoLab
Participated · Series B · May 2024
CoLab offers a cloud-based collaboration platform that lets engineering teams review design files, capture and track feedback, and document issues from a single dashboard. Its tools integrate with enterprise systems like product lifecycle management and allow controlled sharing with suppliers while keeping select information private. Teams at Ford, Johnson Controls and Schneider Electric use CoLab to streamline design reviews and reduce administrative overhead. CoLab operates on a software-as-a-service model and stores customer design data such as 3D models and engineering drawings in the cloud. The company plans to introduce AI features in the coming months, using anonymized customer data to help explain design changes and automate routine tasks. Financially, revenue has doubled in the past six months, paid add-ons are planned this year and next, and the company plans to grow its headcount from 86 (mostly in its Newfoundland headquarters) to about 120 by year end. CoLab provides a web-based co-design and collaboration tool that lets teams share CAD, provide feedback with full mechanical context, and capture design data. The platform standardizes design reviews and simplifies collaboration to accelerate design cycles, drive continuous improvement, and reduce product costs and changes. Co-founded in 2017 by CEO Adam Keating and CTO Jeremy Andrews, the company is based in St John's, Newfoundland and Labrador, Canada. Its tool is used by Fortune 500 customers including Johnson Controls and Hyundai Mobis. CoLab raised $17M in a Series A round led by Insight Partners and plans to use the funds to accelerate the pace of engineering innovation and reinvent how teams collaborate on mechanical design. Josh Fredberg, Managing Director at Insight Partners, joined CoLab's board in conjunction with the financing.
- Swiftsure Innovations
Participated · Seed · Dec 2021
Swiftsure Innovations develops the SwishKit, a device that washes and suctions the oral cavity of mechanically ventilated patients using saline to reduce the risk of ventilator‑acquired pneumonia. The system is designed to clean nasal and oral cavities while minimizing secondary infection risk and improving patient comfort. The company completed its first clinical trials at the Cleveland Clinic last year and is beginning a second clinical study there. Swiftsure has received provincial funding and is committing internal capital to support the next trial as it works toward generating the clinical evidence required for commercial adoption. The company raised $2.3 million in equity funding in 2023. Management says the Cleveland Clinic studies will help validate clinical outcomes, decrease healthcare costs, and enhance patient comfort. Swiftsure Innovations develops and commercializes novel medical devices focused on providing oral-care solutions for critically ill and intubated patients. The company is led by CEO and founder Deanne McCarthy. It raised CAD2.3M in a seed funding round to support commercial activities. The proceeds will enable the company to commercialize SwishKit, an oral care solution for intubated patients. Investors in the round included Pelorus VC (lead), Sandpiper Ventures, the pan-Canadian consortium MEDTEQ+, and several other pre-seed investors. The company is based in Pasadena, Canada. Swiftsure Innovations develops a device for cleaning the mouths and throats of people on ventilators. The company is based in Pasadena, NL. It raised $1.05 million in an oversubscribed seed round. Backers included Threshold Impact, Killick Capital, Pluto Investments, Pelorus Venture Capital and Sandpiper Ventures. The article identifies Sandpiper Ventures as a female-focused venture capital firm.
Team
Mark Dobbin
President and Founder
LinkedIn